{"entity":{"type":"insider","cik":"0001251779","url":"/insider/0001251779","json_url":"/insider/0001251779.json","name":"WEAVER GREGORY L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":18,"first":"2006-05-25","last":"2026-04-01","span_basis":"filed_date"},"name_variants":[{"name":"WEAVER GREGORY L","source":"filing","n_filings":18,"first_seen":"2006-05-25","last_seen":"2026-04-01"}],"transactions":[{"id":6156063,"accession":"0001251779-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001251779-26-000007","line_url":"/filing/0001251779-26-000007#line-1","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.1499,"price_display":"3.15","price_state":"stated","total_value":31499.0,"total_display":"31,499.00","total_whole":"31,499","shares_owned_after":38078.0,"shares_owned_after_display":"38,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-01","scope":"insider"},{"id":6204467,"accession":"0001251779-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001251779-26-000005","line_url":"/filing/0001251779-26-000005#line-1","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.54,"price_display":"3.54","price_state":"stated","total_value":17700.0,"total_display":"17,700.00","total_whole":"17,700","shares_owned_after":28078.0,"shares_owned_after_display":"28,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-09","scope":"insider"},{"id":5206498,"accession":"0001104659-25-023724","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-023724","line_url":"/filing/0001104659-25-023724#line-1","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"Altimmune, Inc.","issuer_ticker":"ALT","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock, par value $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.1996,"price_display":"5.20","price_state":"stated","total_value":51996.0,"total_display":"51,996.00","total_whole":"51,996","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-14","scope":"insider"},{"id":7846687,"accession":"0001437749-23-032461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-032461","line_url":"/filing/0001437749-23-032461#line-1","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"ATOSSA THERAPEUTICS, INC.","issuer_ticker":"ATOS","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Director, Officer (Former EVP, CFO, & Director)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Former EVP, CFO, & Director","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":32500.0,"total_display":"32,500.00","total_whole":"32,500","shares_owned_after":55.0,"shares_owned_after_display":"55","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":7930979,"accession":"0001437749-23-017896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-017896","line_url":"/filing/0001437749-23-017896#line-1","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"ATOSSA THERAPEUTICS, INC.","issuer_ticker":"ATOS","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Director, Officer (EVP & CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":48500.0,"total_display":"48,500.00","total_whole":"48,500","shares_owned_after":50055.0,"shares_owned_after_display":"50,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-20","scope":"insider"},{"id":5221681,"accession":"0001437749-21-016573","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001437749-21-016573","line_url":"/filing/0001437749-21-016573#line-6","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"ATOSSA THERAPEUTICS, INC.","issuer_ticker":"ATOS","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107497.0,"shares_display":"107,497","price_per_share":5.58,"price_display":"5.58","price_state":"stated","total_value":599833.26,"total_display":"599,833.26","total_whole":"599,833","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-07","scope":"insider"},{"id":5132181,"accession":"0000899243-21-025732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-025732","line_url":"/filing/0000899243-21-025732#line-1","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4666.0,"shares_display":"4,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":69990.0,"total_display":"69,990.00","total_whole":"69,990","shares_owned_after":4666.0,"shares_owned_after_display":"4,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-24","scope":"insider"},{"id":6259022,"accession":"0001209191-18-021643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021643","line_url":"/filing/0001209191-18-021643#line-1","is_derivative":false,"issuer_cik":"0001035354","issuer_name":"Eloxx Pharmaceuticals, Inc.","issuer_ticker":"ELOX","issuer_name_source":null,"issuer_url":"/issuer/0001035354","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":8.56,"price_display":"8.56","price_state":"stated","total_value":38520.0,"total_display":"38,520.00","total_whole":"38,520","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-23","filed_date":"2018-03-26","scope":"insider"},{"id":4475357,"accession":"0000904454-13-001238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-001238","line_url":"/filing/0000904454-13-001238#line-1","is_derivative":false,"issuer_cik":"0001251779","issuer_name":"ATOSSA GENETICS INC","issuer_ticker":"ATOS","issuer_name_source":null,"issuer_url":"/issuer/0001251779","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.5785,"price_display":"2.58","price_state":"stated","total_value":25785.0,"total_display":"25,785.00","total_whole":"25,785","shares_owned_after":34510.0,"shares_owned_after_display":"34,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-21","filed_date":"2013-11-22","scope":"insider"},{"id":4628354,"accession":"0001181431-13-059972","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-059972","line_url":"/filing/0001181431-13-059972#line-1","is_derivative":false,"issuer_cik":"0000357097","issuer_name":"Fibrocell Science, Inc.","issuer_ticker":"FCSC","issuer_name_source":null,"issuer_url":"/issuer/0000357097","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.508,"price_display":"3.51","price_state":"stated","total_value":35080.0,"total_display":"35,080.00","total_whole":"35,080","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-20","filed_date":"2013-11-20","scope":"insider"},{"id":5139599,"accession":"0000749647-13-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000749647-13-000003","line_url":"/filing/0000749647-13-000003#line-1","is_derivative":false,"issuer_cik":"0000749647","issuer_name":"Celsion CORP","issuer_ticker":"CLSN","issuer_name_source":null,"issuer_url":"/issuer/0000749647","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Celsion Corporation Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37272.0,"shares_display":"37,272","price_per_share":1.06,"price_display":"1.06","price_state":"stated","total_value":39508.32,"total_display":"39,508.32","total_whole":"39,508","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-19","filed_date":"2013-03-21","scope":"insider"},{"id":8981002,"accession":"0000749647-11-000158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000749647-11-000158","line_url":"/filing/0000749647-11-000158#line-1","is_derivative":false,"issuer_cik":"0000749647","issuer_name":"Celsion CORP","issuer_ticker":"CLSN","issuer_name_source":null,"issuer_url":"/issuer/0000749647","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Celsion Corporation Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":10750.0,"total_display":"10,750.00","total_whole":"10,750","shares_owned_after":28636.0,"shares_owned_after_display":"28,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-06","filed_date":"2011-12-07","scope":"insider"},{"id":9175829,"accession":"0000749647-11-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000749647-11-000066","line_url":"/filing/0000749647-11-000066#line-1","is_derivative":false,"issuer_cik":"0000749647","issuer_name":"Celsion CORP","issuer_ticker":"CLSN","issuer_name_source":null,"issuer_url":"/issuer/0000749647","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Celsion Corporation Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8636.0,"shares_display":"8,636","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":23921.72,"total_display":"23,921.72","total_whole":"23,922","shares_owned_after":23636.0,"shares_owned_after_display":"23,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-26","filed_date":"2011-05-31","scope":"insider"},{"id":7458567,"accession":"0000749647-10-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000749647-10-000047","line_url":"/filing/0000749647-10-000047#line-1","is_derivative":false,"issuer_cik":"0000749647","issuer_name":"Celsion CORP","issuer_ticker":"CLSN","issuer_name_source":null,"issuer_url":"/issuer/0000749647","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Celsion Corporation Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":15500.0,"total_display":"15,500.00","total_whole":"15,500","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-16","filed_date":"2010-09-16","scope":"insider"},{"id":5677140,"accession":"0001179110-09-012401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-09-012401","line_url":"/filing/0001179110-09-012401","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Poniard Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":7.393,"price_display":"7.39","price_state":"stated","total_value":22179.0,"total_display":"22,179.00","total_whole":"22,179","shares_owned_after":9100.0,"shares_owned_after_display":"9,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-08-21","filed_date":"2009-08-21","scope":"insider","n_lines":2},{"id":5798611,"accession":"0001179110-09-006267","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-09-006267","line_url":"/filing/0001179110-09-006267","is_derivative":false,"issuer_cik":"0000755806","issuer_name":"PONIARD PHARMACEUTICALS, INC.","issuer_ticker":"PARD","issuer_name_source":null,"issuer_url":"/issuer/0000755806","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.071375,"price_display":"2.07","price_state":"stated","total_value":4142.75,"total_display":"4,142.75","total_whole":"4,143","shares_owned_after":6775.0,"shares_owned_after_display":"6,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-06","filed_date":"2009-04-06","scope":"insider","n_lines":3},{"id":8190846,"accession":"0001181431-07-014890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-014890","line_url":"/filing/0001181431-07-014890#line-1","is_derivative":false,"issuer_cik":"0000749647","issuer_name":"CELSION CORP","issuer_ticker":"CLN","issuer_name_source":null,"issuer_url":"/issuer/0000749647","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","total_whole":"35,000","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-23","filed_date":"2007-02-27","scope":"insider"},{"id":5580507,"accession":"0001293941-06-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001293941-06-000007","line_url":"/filing/0001293941-06-000007#line-1","is_derivative":false,"issuer_cik":"0000892112","issuer_name":"SIRNA THERAPEUTICS INC","issuer_ticker":"RNAI","issuer_name_source":null,"issuer_url":"/issuer/0000892112","owner_cik":"0001251779","owner_name":"WEAVER GREGORY L","owner_display_name":"WEAVER GREGORY L","owner_url":"/insider/0001251779","role":"Officer (Senior Vice President and CFO)","role_mark":"O","role_mark_label":"Officer (Senior Vice President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":75900.0,"total_display":"75,900.00","total_whole":"75,900","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-25","filed_date":"2006-05-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":18,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001326190","name":"Altimmune, Inc.","url":"/issuer/0001326190","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2025-03-14","last_seen":"2026-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001488039","name":"ATOSSA THERAPEUTICS, INC.","url":"/issuer/0001488039","role":"Director, Officer (Former EVP, CFO, & Director)","n_filings":4,"first_seen":"2013-11-22","last_seen":"2023-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001840904","name":"ATAI Life Sciences N.V.","url":"/issuer/0001840904","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2021-06-24","last_seen":"2021-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001035354","name":"Eloxx Pharmaceuticals, Inc.","url":"/issuer/0001035354","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2018-03-26","last_seen":"2018-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000357097","name":"Fibrocell Science, Inc.","url":"/issuer/0000357097","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2013-11-20","last_seen":"2013-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000749647","name":"Celsion CORP","url":"/issuer/0000749647","role":"Director, Officer (CFO)","n_filings":5,"first_seen":"2007-02-27","last_seen":"2013-03-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000755806","name":"PONIARD PHARMACEUTICALS, INC.","url":"/issuer/0000755806","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2009-04-06","last_seen":"2009-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0000892112","name":"SIRNA THERAPEUTICS INC","url":"/issuer/0000892112","role":"Officer (Senior Vice President and CFO)","n_filings":1,"first_seen":"2006-05-25","last_seen":"2006-05-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001251779","retrieved_at":"2026-08-24T16:38:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}